Association of Endovascular Thrombectomy With Functional Outcome in Patients With Acute Stroke With a Large Ischemic Core

Background and Objectives Endovascular thrombectomy (EVT) is effective for patients with large vessel occlusion (LVO) stroke with smaller volumes of CT perfusion (CTP)-defined ischemic core. However, the benefit of EVT is unclear in those with a core volume >70 mL. We aimed to compare outcomes of EVT and non-EVT patients with an ischemic core volume ≥70 mL, hypothesizing that there would be a benefit from EVT for fair outcome (3-month modified Rankin scale [mRS] 0–3) after stroke. Methods A retrospective analysis of patients enrolled into a multicenter (Australia, China, and Canada) registry (2012–2020) who underwent CTP within 24 hours of stroke onset and had a baseline ischemic core volume ≥70 mL was performed. The primary outcome was the estimation of the association of EVT in patients with core volume ≥70 mL and within 70–100 and ≥100 mL subgroups with fair outcome. Results Of the 3,283 patients in the registry, 299 had CTP core volume ≥70 mL and 269 complete data (135 had core volume between 70 and 100 mL and 134 had core volume ≥100 mL). EVT was performed in 121 (45%) patients. EVT-treated patients were younger (median 69 vs 75 years; p = 0.011), had lower prestroke mRS, and smaller median core volumes (92 [79–116.5] mL vs 105.5 [85.75–138] mL, p = 0.004). EVT-treated patients had higher odds of achieving fair outcome in adjusted analysis (30% vs 13.9% in the non-EVT group; adjusted odds ratio [aOR] 2.1, 95% CI 1–4.2, p = 0.038). The benefit was seen predominantly in those with 70–100 mL core volume (71/135 [52.6%] EVT-treated), with 54.3% in the EVT-treated vs 21% in the non-EVT group achieving a fair outcome (aOR 2.5, 95% CI 1–6.2, p = 0.005). Of those with a core volume ≥100 mL, 50 of the 134 (37.3%) underwent EVT. Proportions of fair outcome were very low in both groups (8.1% vs 8.7%; p = 0.908). Discussion We found a positive association of EVT with the 3-month outcome after stroke in patients with a baseline CTP ischemic core volume 70–100 mL but not in those with core volume ≥100 mL. Randomized data to confirm these findings are required. Classification of Evidence This study provides Class III evidence that EVT is associated with better motor outcomes 3 months after CTP-defined ischemic stroke with a core volume of 70–100 mL.

[1]  K. Toyoda,et al.  Randomized Clinical Trial of Endovascular Therapy for Acute Large Vessel Occlusion with Large Ischemic Core (RESCUE-Japan LIMIT): Rationale and Study Protocol , 2021, Neurologia medico-chirurgica.

[2]  Michael T. Mullen,et al.  SELECTion criteria for large core trials: dogma or data? , 2021, Journal of NeuroInterventional Surgery.

[3]  Kanta Tanaka,et al.  Identifying large ischemic core volume ranges in acute stroke that can benefit from mechanical thrombectomy , 2020, Journal of NeuroInterventional Surgery.

[4]  C. Levi,et al.  Perfusion Computed Tomography Accurately Quantifies Collateral Flow After Acute Ischemic Stroke , 2020, Stroke.

[5]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[6]  J. Grotta,et al.  Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study. , 2019, JAMA neurology.

[7]  Xiaolei Shi,et al.  Predictors of malignant brain edema after mechanical thrombectomy for acute ischemic stroke , 2019, Journal of NeuroInterventional Surgery.

[8]  Michael T. McManus,et al.  Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data , 2019, The Lancet Neurology.

[9]  Xinfeng Yu,et al.  Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment , 2018, Front. Neurol..

[10]  M. Srivastava,et al.  Thrombectomy for Stroke with Selection by Perfusion Imaging. , 2018, The New England journal of medicine.

[11]  C. Levi,et al.  Correction for Delay and Dispersion Results in More Accurate Cerebral Blood Flow Ischemic Core Measurement in Acute Stroke , 2018, Stroke.

[12]  R. Nogueira,et al.  Thrombectomy 6 to 24 Hours after Stroke. , 2018, The New England journal of medicine.

[13]  C. Levi,et al.  Evaluation of hyperacute infarct volume using ASPECTS and brain CT perfusion core volume , 2017, Neurology.

[14]  Seena Dehkharghani,et al.  Endovascular Treatment for Patients With Acute Stroke Who Have a Large Ischemic Core and Large Mismatch Imaging Profile , 2017, JAMA neurology.

[15]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[16]  Hester F. Lingsma,et al.  Value of Computed Tomographic Perfusion–Based Patient Selection for Intra-Arterial Acute Ischemic Stroke Treatment , 2015, Stroke.

[17]  H. Diener,et al.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. , 2015, The New England journal of medicine.

[18]  A. Demchuk,et al.  Thrombectomy within 8 hours after symptom onset in ischemic stroke. , 2015, The New England journal of medicine.

[19]  M. Krause,et al.  Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.

[20]  Eric E. Smith,et al.  Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.

[21]  Hester F. Lingsma,et al.  A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.

[22]  C. Levi,et al.  Perfusion CT in acute stroke: a comprehensive analysis of infarct and penumbra. , 2013, Radiology.

[23]  Manabu Inoue,et al.  MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study , 2012, The Lancet Neurology.

[24]  M. Parsons,et al.  Aspectasaurus (A Dinosaur)? , 2012, International journal of stroke : official journal of the International Stroke Society.

[25]  C. Levi,et al.  Perfusion computer tomography: imaging and clinical validation in acute ischaemic stroke. , 2011, Brain : a journal of neurology.

[26]  Geoffrey A. Donnan,et al.  Refining the Definition of the Malignant Profile: Insights From the DEFUSE-EPITHET Pooled Data Set , 2011, Stroke.

[27]  C. Levi,et al.  The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. , 2009, Brain : a journal of neurology.

[28]  Keith Muir,et al.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.

[29]  Scott Hamilton,et al.  Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study , 2006, Annals of neurology.

[30]  A. Satterfield,et al.  TREATMENT , 1924, California and western medicine.